Solara Active Pharma Sciences Limited — Quarter ended March 31, 2026 (Published May 15, 2026)
| The BSE Limited | The National Stock Exchange of India Limited |
|---|---|
| Phiroze Jeejeebhoy Towers | Exchange Plaza, C-1, Block G, Bandra-Kurla |
| Dalal Street, Mumbai – 400 001 | Complex, Bandra (E), Mumbai – 400 051 |
| Sl. No. | Particulars | 3 months ended 31.03.2026 (Refer note 10) | Preceding 3 months ended 31.12.2025 UNAUDITED | Corresponding 3 months ended in the previous year 31.03.2025 (Refer note 10) | Financial Year ended 31.03.2026 AUDITED | Previous Financial Year ended 31.03.2025 AUDITED |
|---|---|---|---|---|---|---|
| I | Revenue from operations | 387.29 | 349.00 | 273.01 | 1,368.98 | 1,283.76 |
| II | Other income | 4.69 | 0.00 | 5.95 | 6.16 | 8.32 |
| III | Total income (I + II) | 391.98 | 349.00 | 278.96 | 1,375.14 | 1,292.08 |
| IV | Expenses | |||||
| (a) | Cost of materials consumed | 182.23 | 175.71 | 143.67 | 672.77 | 581.66 |
| (b) | Purchases of stock-in-trade | 0.77 | 2.72 | 5.05 | 3.49 | 5.75 |
| (c) | Changes in inventories of finished goods, stock-in-trade and work in progress | 14.44 | 8.17 | (30.63) | 8.25 | 39.00 |
| (d) | Employee benefits expenses | 55.47 | 55.23 | 52.29 | 219.20 | 211.69 |
| (e) | Finance costs | 27.57 | 22.45 | 29.12 | 94.75 | 114.81 |
| (f) | Depreciation and amortisation expenses | 26.04 | 25.57 | 24.30 | 99.68 | 99.25 |
| (g) | Other expenses | 76.72 | 69.83 | 57.26 | 278.52 | 239.38 |
| Total expenses (IV) | Total expenses (IV) | 383.24 | 359.68 | 281.06 | 1,376.66 | 1,291.54 |
| V | Profit/(loss) before exceptional item and tax (III – IV) | 8.74 | (10.68) | (2.10) | (1.52) | 0.54 |
| VI | Exceptional item profit / (loss) (Refer note 6) | 0.86 | (6.75) | – | (5.89) | – |
| VII | Profit/(loss) before tax (V – VI) | 9.60 | (17.43) | (2.10) | (7.41) | 0.54 |
| VIII | Tax expense | |||||
| – Current tax | – | – | – | – | – | |
| – Deferred tax | – | – | – | – | – | |
| Total tax expense (VIII) | Total tax expense (VIII) | – | – | – | – | – |
| IX | Profit/(loss) for the period /year (VII -VIII) | 9.60 | (17.43) | (2.10) | (7.41) | 0.54 |
| X | Other comprehensive income | |||||
| A | Items that will not be reclassified subsequently to profit or loss: | |||||
| (i) | Remeasurement gains of defined benefit plans | 0.71 | 1.60 | (0.64) | 3.27 | 1.06 |
| (ii) | Income tax relating to items that will not be reclassified subsequently to profit or loss | – | – | – | – | – |
| B | Items that may be reclassified to subsequently to profit or loss: | |||||
| (i) | Exchange differences on translating the financial statements of foreign operations | (0.21) | (0.05) | 0.02 | (0.42) | (0.08) |
| (ii) | Income tax relating to items that may be reclassified to statement of profit and loss | – | – | – | – | – |
| Total other comprehensive income for the period / year (X) | Total other comprehensive income for the period / year (X) | 0.50 | 1.55 | (0.62) | 2.85 | 0.98 |
| XI | Total comprehensive income/(loss) for the period / year (IX + X) | 10.10 | (15.88) | (2.72) | (4.56) | 1.52 |
| XII | Profit for the year attributable to: | |||||
| – Equity shareholders of the Company | 9.60 | (17.43) | (2.10) | (7.41) | 0.54 | |
| – Non-controlling interests | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | |
| XIII | Other Comprehensive income attributable to: | |||||
| – Equity shareholders of the Company | 0.50 | 1.55 | (0.62) | 2.85 | 0.98 | |
| – Non-controlling interests | – | – | – | – | – | |
| XIV | Total Comprehensive income attributable to: | |||||
| – Equity shareholders of the Company | 10.10 | (15.88) | (2.72) | (4.56) | 1.52 | |
| – Non-controlling interests | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | |
| XV | Paid-up equity share capital (face value of Rs. 10/- each) | 44.51 | 44.49 | 40.25 | 44.51 | 40.25 |
| XVI | Other equity excluding Non-controlling interest | – | – | – | 1,208.37 | 1,053.99 |
| Particulars | 3 months ended 31.03.2026 | Preceding 3 months ended 31.12.2025 | Corresponding 3 months ended 31.03.2025 | Financial Year ended 31.03.2026 | Previous Financial Year ended 31.03.2025 |
|---|---|---|---|---|---|
| (a) Basic (in Rs.) | 2.20 | (3.98) | (0.93) | (1.68) | 0.14 |
| (b) Diluted (in Rs.) | 2.20 | (3.98) | (0.93) | (1.68) | 0.14 |
| Sl. No. | Particulars | As at March 31, 2026 (AUDITED) | As at March 31, 2025 (AUDITED) |
|---|---|---|---|
| A I | Assets | ||
| Non-current assets | |||
| (a) | Property, plant and equipment† | 793.18 | 738.68 |
| (b) | Right of use assets | 57.23 | 57.74 |
| (c) | Capital work in progress | 204.79 | 280.05 |
| (d) | Investment property | – | 2.28 |
| (e) | Goodwill | 364.90 | 364.90 |
| (f) | Other intangible assets | 22.20 | 29.80 |
| (g) | Financial assets | ||
| (i) Investments | 1.62 | 1.70 | |
| (ii) Other financial assets | 16.74 | 16.32 | |
| (h) | Income tax assets (net) | 6.63 | 4.52 |
| (i) | Other non-current assets | 7.20 | 7.12 |
| Total non-current assets | 1,474.49 | 1,503.11 | |
| II | Current assets | ||
| (a) | Inventories | 317.87 | 317.90 |
| (b) | Financial assets | ||
| (i) Investments | 3.00 | – | |
| (ii) Trade receivables | 438.72 | 326.57 | |
| (iii) Cash and cash equivalents | 4.48 | 3.95 | |
| (iv) Bank balances other than (iii) above | 45.86 | 0.16 | |
| (v) Loans | 0.03 | 0.02 | |
| (vi) Other financial assets | 6.54 | 12.36 | |
| (c) | Other current assets | 41.60 | 67.77 |
| Total current assets | 858.10 | 728.73 | |
| Total Assets (I+II) | 2,332.59 | 2,231.84 | |
| B I | Equity and Liabilities | ||
| Equity | |||
| (a) | Equity Share capital | 44.51 | 40.25 |
| (b) | Other equity | 1,208.37 | 1,053.99 |
| Equity attributable to the owners of the Company | 1,252.88 | 1,094.24 | |
| Non-controlling interests | 2.67 | 2.67 | |
| Total Equity | 1,255.55 | 1,096.91 | |
| II | Liabilities | ||
| 1 | Non-current liabilities | ||
| (a) | Financial liabilities | ||
| (i) Borrowings | 110.45 | 113.86 | |
| (ii) Lease liabilities | 19.21 | 17.77 | |
| (iii) Other financial liabilities | – | 0.42 | |
| (b) | Provisions | 53.47 | 58.77 |
| Total Non-current liabilities | 183.13 | 190.82 | |
| 2 | Current liabilities | ||
| (a) | Financial liabilities | ||
| (i) Borrowings | 554.09 | 662.20 | |
| (ii) Lease liabilities | 2.81 | 2.25 | |
| (iii) Trade payables | |||
| – Dues of micro and small enterprises | 19.19 | 37.99 | |
| – Dues of other than micro and small enterprises | 254.71 | 209.61 | |
| (iv) Other financial liabilities | 32.86 | 18.91 | |
| (b) | Provisions | 13.88 | 2.23 |
| (c) | Current tax liabilities (net) | 0.01 | 0.01 |
| (d) | Other current liabilities | 16.36 | 10.91 |
| Total current liabilities | 893.91 | 944.11 | |
| Total liabilities | 1,077.04 | 1,134.93 | |
| Total Equity and Liabilities (I+II) | 2,332.59 | 2,231.84 |
| Sl. No. | Particulars | For the year ended March 31, 2026 (AUDITED) | For the year ended March 31, 2025 (AUDITED) |
|---|---|---|---|
| A | Cash flow from operating activities | ||
| Profit / (loss) before tax for the year | (7.41) | 0.54 | |
| Adjustments for: | |||
| Depreciation and amortisation expenses | 99.68 | 99.25 | |
| Finance costs | 94.75 | 114.81 | |
| Share based compensation expenses (net of reversals) | 4.67 | 2.68 | |
| Rental income from investment property | (1.07) | (1.02) | |
| Interest income | (1.37) | (0.76) | |
| Liabilities / provisions no longer required written back | (0.49) | (4.43) | |
| Loss on sale and / or write-off of property, plant and equipment | 0.26 | 0.08 | |
| Bad debts written off / Allowance for doubtful trade and other receivables | 3.94 | 1.02 | |
| Unrealised exchange (gain)/loss (net) | 0.24 | (1.47) | |
| Operating cash flows before working capital changes | 193.20 | 210.70 | |
| Changes in working capital: | |||
| Adjustments for (increase) / decrease in operating assets: | |||
| – Inventories | 0.03 | 41.80 | |
| – Trade receivables | (111.32) | 19.81 | |
| – Other assets (financial & non-financial) | 32.03 | (10.02) | |
| Adjustments for increase / (decrease) in operating liabilities: | |||
| – Trade payables | 25.90 | (59.43) | |
| – Other liabilities (financial & non-financial) | 15.19 | 10.86 | |
| Cash generated from operations | 155.03 | 213.72 | |
| Net income tax paid | (2.12) | (0.90) | |
| Net cash flow generated from operating activities (A) | 152.91 | 212.82 | |
| B | Cash flow from investing activities | ||
| Capital expenditure for property, plant and equipments and intangible assets, including capital advances | (52.82) | (39.94) | |
| Investments in deposits with banks | (45.70) | – | |
| Investments in mutual funds | (3.00) | – | |
| Proceeds from sale of property, plant and equipment | 0.51 | 0.38 | |
| Rental income from investment property | 1.07 | 1.02 | |
| Proceeds from sale of investments in other entities | 0.08 | 0.96 | |
| Interest received | 1.03 | 0.75 | |
| Net cash flow utilised in investing activities (B) | (98.83) | (36.83) | |
| C | Cash flow from financing activities | ||
| Proceeds from issue of equity shares | 158.52 | 159.02 | |
| Share issue expenses | – | (2.89) | |
| Proceeds from non-current borrowings | 49.50 | 75.00 | |
| Repayment of non-current borrowings | (88.89) | (110.95) | |
| Net increase / (decrease) in current borrowings | (76.81) | (185.43) | |
| Lease payments | (3.63) | (2.13) | |
| Finance costs | (92.24) | (113.10) | |
| Net cash flow utilised in financing activities (C) | (53.55) | (180.48) | |
| Net increase in cash and cash equivalents (A+B+C) | 0.53 | (4.49) | |
| Cash and cash equivalents at the beginning of the year | 3.95 | 8.44 | |
| Cash and cash equivalents at the end of the year |